International Guideline Harmonization Group
The IGHG
The International Late Effects of Childhood Cancer Guideline Harmonization Group, IGHG, is a collaborative endeavor, founded in 2010. The IGHG develops international guidelines for the long-term follow-up of childhood, adolescent, and young adult cancer survivors.
International collaboration has key advantages in terms of reducing duplication of efforts, optimizing the use of expertise, and identifying gaps in knowledge.
Goal
Our main goal is to establish a common vision and integrated strategy for the surveillance of chronic health problems in childhood, adolescent, and young adult cancer survivors.
We aim to:
- Promote healthy lifestyles
- Provide ongoing monitoring of health status
- Facilitate early detection of late effects
- Advise about timely intervention strategies to preserve health
Published guidelines
- Breast cancer surveillance
- Cardiomyopathy surveillance, update in progress
- Premature ovarian insufficiency surveillance
- Male gonadotoxicity surveillance
- Thyroid cancer surveillance
- Ototoxicity surveillance
- Obstetric care
- Central nervous system neoplasm surveillance
- Fatigue surveillance
- Psychosocial problems surveillance
- Mental health problems surveillance
- Coronary artery disease surveillance
- Fertility preservation
- Bone mineral density surveillance
- Hepatic toxicity surveillance
- Hypothalamic-pituitary dysfunction surveillance
- COVID-19 statement
Guidelines in progress
- Metabolic syndrome surveillance
- Nephrotoxicity surveillance
- Colorectal cancer surveillance
- Pulmonary dysfunction surveillance
- Splenic dysfunction surveillance
- Neurocognitive problems surveillance
- Dexrazoxane
- Growth hormone treatment
With the initiation of the IGHG we have made a commitment to collaborative guideline development with the ultimate goal of optimizing quality of care and improving quality of life for childhood, adolescent, and young adult cancer survivors.
We welcome all individuals who are willing to contribute to the initiative.